Related Experiment Video
Updated: Jul 9, 2026

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Adolescent and young women's experience with the vaginal ring and oral contraceptive pills
Felicia H Stewart1, Beth A Brown, Tina R Raine
1The Bixby Center for Reproductive Health Research & Policy, Department of Obstetrics, Gynecology & Reproductive Sciences, The University of California, San Francisco, CA 94118, USA.
Study Objective:
To compare acceptability of the vaginal contraceptive ring to that of oral contraceptive pills.
Design:
Randomized, cross-over, 6-month study.
Setting:
Urban family planning clinic for young low-income patients.
Participants:
Sexually active females aged 15-21 years (n = 130).
Interventions:
Participants were randomly assigned to use the vaginal ring or oral contraceptive pills for an initial study interval of three 28-day cycles, followed by three cycles of the alternate method.
Main Outcome Measures:
Participants completed surveys about method use, acceptability, and side effects at baseline, after three cycles, and after six cycles. We analyzed study data using ANOVA models for cross-over designs.
Results:
We did not detect higher compliance with the ring as compared to oral contraceptive pills (P = 0.176), although overall approval of the ring was significantly higher on several items measured, including liked using method (P = 0.015), would recommend it to friends (P = 0.012), and not as hard to remember to use method correctly (P < or = 0.000). Participants were less worried about health risks while using the ring (P = 0.006), but reported that the ring was more likely to interfere with sex than the pill (P < or = 0.001) and that sex partners liked the pill (P = 0.034). Most women did not report bothersome side effects with either method.
Conclusions:
Adolescent and young women showed favorable acceptability of the vaginal contraceptive ring compared to oral contraceptive pills.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Disorders of the Female Reproductive System
Oral Drug Delivery Systems: Continuous-Release Systems

